Logo

MiRxes: Dan Headon

Nov 17, 2021

MiRxes, a Singapore-based developer of RNA-powered disease early detection tests, has appointed Dan Headon as senior VP of marketing. Based in Australia, Headon will report to MiRxes CEO Lihan Zhou. From 2008 to 2017, Headon was director of marketing for APAC at Illumina. He also worked for 14 years for Applied Biosystems, starting his career in sales and eventually retaining the roles of business director for the applied markets division and marketing director for East Asia, China, and Oceania.

Breaking News
The Scan

RNA Editing in Octopuses Seems to Help Acclimation to Shifts in Water Temperature

A paper in Cell reports that octopuses use RNA editing to help them adjust to different water temperatures.

Topical Compound to Block EGFR Inhibitors May Ease Skin Toxicities, Study Finds

A topical treatment described in Science Translational Medicine may limit skin toxicities seen with EGFR inhibitor therapy.

Dozen Genetic Loci Linked to Preeclampsia Risk in New GWAS

An analysis of genome-wide association study data in JAMA Cardiology finds genetic loci linked to preeclampsia that have ties to blood pressure.

Cancer Survival Linked to Mutational Burden in Pan-Cancer Analysis

A pan-cancer paper appearing in JCO Precision Oncology suggests tumor mutation patterns provide clues for predicting cancer survival that are independent of other prognostic factors.